Suchergebnisse: First Line

Bendamustine in Metastatic Breast Cancer: An Old Drug in New Design

Pirvulescu, Cristina ; Minckwitz, Gunter von ; Loibl, Sibylle

Help-seeking behavior, treatment barriers and facilitators, attitudes and access to first-line treatment in German adults with obsessive-compulsive disorder

Bey, Katharina ; Willems, Severin ; Dueren, Anna Lena ; Philipsen, Alexandra ; Wagner, Michael

Tislelizumab versus Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma: Impact on Health-Related Quality of Life in RATIONALE-301 Study

Finn, Richard S. ; Kudo, Masatoshi ; Barnes, Gisoo ; Meyer, Tim ; Boisserie, Frederic ; Abdrashitov, Ramil ; Chen, Yaxi ; Li, Songzi ; Zhu, Andrew X. ; Qin, Shukui ; Vogel, Arndt

Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study

Berger, Tamar ; Shochat, Tzippy ; Aumann, Shlomzion ; Nachmias, Boaz ; Goldschmidt, Neta ; Horesh, Nurit ; Harel, Reut ; Aviv, Ariel ; Shmerts, Ella ; Abadi, Uri ; Shimony, Shai ; Raanani, Pia ; Gafter‑Gvili, Anat ; Gurion, Ronit

Flatness based trajectory planning for a semi‐linear hyperbolic system of first order p.d.e. modeling a tubular reactor

Woittennek, Frank ; Rudolph, Joachim ; Knüppel, Torsten

Macromolecular Viral Entry Inhibitors as Broad‐Spectrum First‐Line Antivirals with Activity against SARS‐CoV‐2

Groß, Rüdiger Martin ; Dias Loiola, Lívia Mesquita ; Issmail, Leila ; Uhlig, Nadja ; Eberlein, Valentina ; Conzelmann, Carina ; Olari, Lia‐Raluca ; Rauch, Lena ; Lawrenz, Jan ; Weil, Tatjana ; Müller, Janis A. ; Cardoso, Mateus Borba ; Gilg, Andrea ; Larsson, Olivia ; Höglund, Urban ; Pålsson, Sandra Axberg ; Tvilum, Anna Selch ; Løvschall, Kaja Borup ; Kristensen, Maria M. ; Spetz, Anna‐Lena ; Hontonnou, Fortune ; Galloux, Marie ; Grunwald, Thomas ; Zelikin, Alexander N. ; Münch, Jan

C‐reactive protein flare‐response predicts long‐term efficacy to first‐line anti‐PD‐1‐based combination therapy in metastatic renal cell carcinoma

Klümper, Niklas ; Schmucker, Philipp ; Hahn, Oliver ; Höh, Benedikt ; Mattigk, Angelika ; Banek, Severine ; Ellinger, Jörg ; Heinzelbecker, Julia ; Sikic, Danijel ; Eckstein, Markus ; Strauß, Arne ; Zengerling, Friedemann ; Hölzel, Michael ; Zeuschner, Philip ; Kalogirou, Charis 2021 Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation

Landre, Thierry ; Des Guetz, Gaetan ; Chouahnia, Kader ; Duchemann, Boris ; Assié, Jean-Baptiste ; Chouaid, Christos

New first line treatment options of clear cell renal cell cancer patients with PD-1 or PD-L1 immune-checkpoint inhibitor-based combination therapies

Grimm, Marc-Oliver ; Leucht, Katharina ; Grünwald, Viktor ; Foller, Susan 2020 Friedrich-Schiller-Universität Jena

Clozapine as a first- or second-line treatment in schizophrenia: a systematic review and meta-analysis

Okhuijsen-Pfeifer, C. ; Huijsman, E. A. H. ; Hasan, Alkomiet ; Sommer, I. E. C. ; Leucht, S. ; Kahn, R. S. ; Luykx, J. J. 2018 Universität Augsburg

A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study

Harbeck, Nadia ; Saupe, Steffen ; Jäger, Elke ; Schmidt, Marcus ; Kreienberg, Rolf ; Müller, Lothar ; Otremba, Burkhard Joerg ; Waldenmaier, Dirk ; Dorn, Julia ; Warm, Mathias ; Scholz, Michael ; Untch, Michael ; Wit, Maike de ; Barinoff, Jana ; Lück, Hans-Joachim ; Harter, Philipp ; Augustin, Doris ; Harnett, Paul ; Beckmann, Matthias Wilhelm ; Al-Batran, Salah-Eddin

P-move: a randomized control trial of exercise in patients with advanced pancreatic or biliary tract cancer (aPBC) receiving beyond first-line chemotherapy

Lazzari, Nico de ; Götte, Miriam ; Kasper-Virchow, Stefan ; Meier, Eileen ; Schuler, Martin ; Pogorzelski, Michael ; Siveke, Jens ; Tewes, Mitra

Early CRP kinetics to predict long‐term efficacy of first‐line immune‐checkpoint inhibition combination therapies in metastatic renal cell carcinoma – an updated multicentre real‐world experience applying different CRP kinetics definitions

Hoeh, Benedikt ; Garcia, Cristina Cano ; Banek, Severine ; Klümper, Niklas ; Cox, Alexander ; Ellinger, Jörg ; Schmucker, Philipp ; Hahn, Oliver ; Mattigk, Angelika ; Zengerling, Friedemann ; Becker, Philippe ; Erdmann, Kati ; Buerk, Bjoern Thorben ; Flegar, Luka ; Huber, Johannes ; Kalogirou, Charis Alexis Thomas ; Zeuschner, Philip 2023 Saarländische Universitäts- und Landesbibliothek

Trends and Disparities in Clinical Trial Enrollment as Part of First-Line Treatment for Upper Gastrointestinal and Hepatopancreatobiliary Malignancies

Rhodin, Kristen E. ; Raman, Vignesh ; Kanu, Elishama ; Eckhoff, Austin ; Nussbaum, Daniel P. ; Lidsky, Michael E. ; Blazer, Dan G.

NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients

Schirripa, Marta ; Zhang, Wu ; Yang, Dongyun ; Cao, Shu ; Okazaki, Satoshi ; Loupakis, Fotios ; Berger, Martin D. ; Ning, Yan ; Miyamoto, Yuji ; Suenaga, Mitsukuni 2018 Ludwig-Maximilians-Universität München

Impact of the Specific Mutation in KRAS Codon 12 Mutated Tumors on Treatment Efficacy in Patients with Metastatic Colorectal Cancer Receiving Cetuximab-Based First-Line Therapy: A Pooled Analysis of Three Trials

Modest, Dominik Paul ; Brodowicz, Thomas ; Stintzing, Sebastian ; Jung, Andreas ; Neumann, Jens ; Laubender, Ruediger P. ; Ocvirk, Janja ; Kurteva, Galina ; Papai, Zsuzsanna ; Knittelfelder, Regina 2012 Ludwig-Maximilians-Universität München

Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

Rautenberg, Christina ; Stölzel, Friedrich ; Röllig, Christoph ; Stelljes, Matthias ; Gaidzik, Verena ; Lauseker, Michael ; Kriege, Oliver ; Verbeek, Mareike ; Unglaub, Julia Marie ; Thol, Felicitas ; Krause, Stefan W. ; Hänel, Mathias ; Neuerburg, Charlotte ; Vučinić, Vladan ; Jehn, Christian-Friedrich ; Severmann, Julia ; Wass, Maxi ; Fransecky, Lars ; Chemnitz, Jens ; Holtick, Udo ; Schäfer-Eckart, Kerstin ; Schröder, Josephine ; Kraus, Sabrina ; Krüger, William H. ; Kaiser, Ulrich ; Scholl, Seba 2021 Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)

First‐line nab‐paclitaxel plus carboplatin for patients with advanced non‐small cell lung cancer: results of the NEPTUN study

Dechow, Tobias ; Riera‐Knorrenschild, Jorge ; Hackanson, Björn ; Janssen, Jan ; Schulz, Holger ; Chiabudini, Marco ; Fischer von Weikersthal, Ludwig ; Budweiser, Stephan ; Nacke, Axel ; Taeuscher, Dagmar ; Welslau, Manfred ; Potthoff, Karin 2021 Universität Augsburg

Patient-reported outcomes from the phase II FAST trial of zolbetuximab plus EOX compared to EOX alone as first-line treatment of patients with metastatic CLDN18.2+ gastroesophageal adenocarcinoma

Lordick, Florian ; Batran, Salah-Eddin al- ; Ganguli, Arijit ; Morlock, Robert ; Sahin, Ugur ; Türeci, Özlem

Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma

Alsina, Angel ; Kudo, Masatoshi ; Vogel, Arndt ; Cheng, Ann-Lii ; Tak, Won Young ; Ryoo, Baek-Yeol ; Evans, Thomas R. Jeffry ; López López, Carlos ; Daniele, Bruno ; Misir, Soamnauth ; Ren, Min ; Izumi, Namiki ; Qin, Shukui ; Finn, Richard S.